NCT01194960 2020-10-19
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Oxford BioMedica
Phase 2 Terminated
Clinical Trials
3 trialsNCT00448409 2016-03-17
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
The Methodist Hospital Research Institute
Phase 2 Completed
NCT00521274 2016-03-17
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
The Methodist Hospital Research Institute
Phase 2 Terminated